YIM v. NATIONAL INSTITUTES OF HEALTH

CourtDistrict Court, D. New Jersey
DecidedMarch 29, 2023
Docket3:21-cv-07031
StatusUnknown

This text of YIM v. NATIONAL INSTITUTES OF HEALTH (YIM v. NATIONAL INSTITUTES OF HEALTH) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
YIM v. NATIONAL INSTITUTES OF HEALTH, (D.N.J. 2023).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

JIN-PYONG PETER YIM,

Plaintiff, Civil Action No. 21-07031 (ZNQ) (LHG)

v. OPINION

NATIONAL INSTITUTES OF HEALTH,

Defendant.

QURAISHI, District Judge THIS MATTER comes before the Court upon a Motion for Summary Judgment filed by Defendant National Institutes of Health (“Defendant” or “NIH”) pursuant to Rule 56 of the Federal Rules of Civil Procedure (ECF Nos. 18, 19). Defendant filed a Memorandum of Law in Support of the Motion (“Moving Br.”, ECF No. 18), a Statement of Material Facts (“Def. SMF”, ECF No. 19). Plaintiff Jin-Pyong Peter Yim (“Plaintiff” or “Yim”) filed a Brief in Opposition to the Motion (“Opp. Br.”, ECF No. 24), along with a Response to Defendant’s Statement of Material Facts (“Plf. SMF”, ECF No. 24-1). Defendant replied. (ECF No. 27.) The Court has carefully considered the parties’ submissions and decides the matter without oral argument pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1. For the reasons set forth below, the Court will GRANT Defendant’s Motion for Summary Judgment. I. BACKGROUND AND PROCEDURAL HISTORY This matter concerns pro se Plaintiff’s request to NIH pursuant to the Freedom of Information Act (“FOIA”), 5 U.S.C. § 552, for certain documents and records relating to NIH’s COVID-19 treatment guidelines and recommendations. (Def. SMF ¶ 1.) Specifically, on or about January 28, 2021, Plaintiff requested: “All updates to the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines that were endorsed by a vote of the Panel. (Date Range for Record Search: From 01/01/2021 To 01/28/2021)”. (Id. ¶ 2.) Approximately two months later, Plaintiff filed his

FOIA complaint on March 31, 2021. (Complaint (“Cmpl.”), ECF No. 1.) On April 23, 2021, Defendant determined that Plaintiff’s requested records were made public and were posted on the NIH official government website. (Def. SMF ¶ 6; Declaration of Gorka Garcia-Malene (“Garcia-Malene Decl.”), Ex. 4, ECF No. 20.) During the requested time period, the only update to the NIH’s Guidelines concerned the drug ivermectin, which Defendant published on January 14, 2021, on its website.1 (Cmpl. ¶ 22; Answer ¶ 22, ECF No. 9; Declaration of Jin-Pyong Peter Yim (“Yim Decl.”) ¶ 3, ECF No. 24-3.) The parties’ attempts to resolve this matter through email correspondence during this time were unsuccessful. (See Garcia-Malene Decl., Ex. 6; Yim Decl., Exs. A, B, C, ECF Nos. 24-4, 24-5, 24-6; Defendant’s Status Update Letter dated September 8, 2021 (“Def. Ltr.”), Exs. A, B, C, ECF Nos. 16-1, 16-3, 16-5.)

On May 10, 2021, the Court denied Defendant’s request for an expedited status conference to determine whether the NIH had provided Plaintiff with documents responsive to his request and thereby mooted the matter. (ECF Nos. 5, 7.) Pursuant to a status conference held before the Court on August 25, 2021, the Magistrate Judge ordered the parties to confer to attempt to resolve their dispute. (ECF Nos. 11, 12, 13.) Following the status conference, on August 26, 2021, Defendant contacted Plaintiff via email asking him to supply the exact web link he would like the NIH to certify as the responsive

1 The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Ivermectin for the Treatment of COVID-19 (Jan. 14, 2021), https://files.covid19treatmentguidelines.nih.gov/guidelines/archive/statement-on-ivermectin-01-14-2021.pdf (“NIH Link”.) record to his FOIA request. (Def. SMF ¶ 18; Def. Ltr., Ex. D, ECF No. 16-6.) Plaintiff replied that the link to the specific record that would be responsive to the FOIA request was the NIH Link. (Def. Ltr., Ex. E, ECF No. 16-7.) In response, on August 27, 2021, Defendant stated via email the following:

Please be advised that the link you supplied, to wit [NIH Link], is a valid NIH link that directs you to the document responsive to your FOIA request (#55822). As you will recall, on or about May 5, 2021, the NIH supplied you with the link to the archive tab and with specific directions regarding how to find the exact document you requested. It appears you were able to locate the publicly available document with those directions. (Def. Ltr., Ex. F, ECF No. 16-8; Yim Decl., Ex. D, ECF No. 24-7.) Yim replied on August 27, 2021, that he wanted “this change to be reflected in a formal NIH FOIA response letter.” (Def. SMF ¶ 22; Def. Ltr., Ex. G, ECF No. 16-10.) Following Defendant’s request for the exact language which Plaintiff would like included in NIH’s response letter, Plaintiff replied: “[t]he language from your previous email is fine. I am interested to know if an NIH employee is willing to sign the letter.” (Def. SMF ¶¶ 23, 24; Def. Ltr., Ex. I, ECF No. 16-12.) On September 1, 2021, Defendant transmitted to Plaintiff a revised letter dated August 31, 2021, from NIH regarding his FOIA request. (Def. Ltr., Ex. J, ECF No. 16-13; Yim Decl. ¶ 22.) The letter was signed by Gorka Garcia-Malene, FOIA Officer for NIH and contained the following language: Please be advised that [NIH Link], is a valid NIH link that directs you to the document responsive to your FOIA request date range from 1/01/2021 to 0/28/2021 (#55822). As you will recall, on or about May 5, 2021, the NIH supplied you with the link to the archive tab and with specific directions regarding how to find the exact document you requested. It appears you were able to locate the publicly available document with those directions. (Def. Ltr., Ex. J-1, ECF No. 16-14; Yim Decl., Ex. E, ECF No. 24-8) (emphasis added.) On September 2, 2021, Plaintiff submitted a “status update” letter to this Court stating that he made a settlement offer to Defendant but “Defendant has not agreed to that offer.” (Plaintiff’s Status Update Letter dated September 2, 2021 (“Plf. Ltr.”), ECF No. 14.) Specifically, Plaintiff wrote that he would accept, as Defendant’s FOIA response, Defendant’s statement on August 27,

2021, confirming that the NIH Link directed him to documents responsive to his request “provided that an employee of the NIH signs a document with that statement.” (Id.) The instant motion ensued. II. LEGAL STANDARD FOIA cases are typically adjudicated by summary judgment. Manna v. United States Dep’t of Justice, 832 F. Supp. 866, 870 (D.N.J. 1993), aff’d, 51 F.3d 1158 (3d Cir. 1995). A “court shall grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). “Only disputes over facts that might affect the outcome of the suit under the governing law will properly preclude the entry of summary judgment.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248

(1986). A material fact raises a “genuine” dispute “if the evidence is such that a reasonable jury could return a verdict for the nonmoving party.” Williams v. Borough of W. Chester, 891 F.2d 458, 459 (3d Cir. 1989) (quoting Anderson, 477 U.S. at 248). “In evaluating the evidence, the Court must consider all facts and their logical inferences in the light most favorable to the non-moving party.” Rhodes v. Marix Servicing, LLC, 302 F. Supp. 3d 656, 661 (D.N.J. 2018) (citing Curley v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
United States Department of Justice v. Tax Analysts
492 U.S. 136 (Supreme Court, 1989)
Valencia-Lucena v. United States Coast Guard
180 F.3d 321 (D.C. Circuit, 1999)
Ponta-Garcia v. Attorney General of the United States
446 F. App'x 447 (Third Circuit, 2011)
Siegel Transfer, Inc. v. Carrier Express, Inc.
54 F.3d 1125 (Third Circuit, 1995)
Manna v. United States Department of Justice
832 F. Supp. 866 (D. New Jersey, 1993)
O'Connor v. United States Department of Treasury
570 F. Supp. 2d 749 (E.D. Pennsylvania, 2008)
Manna v. United States Department of Justice
815 F. Supp. 798 (D. New Jersey, 1993)
Canning v. U.S. Department of Defense
499 F. Supp. 2d 14 (District of Columbia, 2007)
Judicial Watch, Inc. v. United States Food & Drug Administration
514 F. Supp. 2d 84 (District of Columbia, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
YIM v. NATIONAL INSTITUTES OF HEALTH, Counsel Stack Legal Research, https://law.counselstack.com/opinion/yim-v-national-institutes-of-health-njd-2023.